Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07172243Recruiting

BE.Amycon Biobank & Data Registry UZ Leuven

Role: collaborator

NCT06998355Suspended

BE.Amycon Registry UZ Leuven

Role: collaborator

NCT04996238Not ApplicableCompleted

Local and General Immune Response After Coronavirus Disease (COVID-19) Vaccination in Volunteers

Role: collaborator

NCT04102891Not ApplicableUnknown

Health Improvement Through Food and Lifestyle Intervention Based On Personalized Retail Advice

Role: collaborator

NCT02689193Completed

IDIS Project Work Package 2: Establishing a Biobank at ITM and Collaborating Centres

Role: collaborator

All 5 trials loaded